United States Federal law regulates the sale of Medical Devices. The US Food and Drug Administration (FDA) grants clearance to manufacturers to market devices for specific indications, after safety and efficacy have been demonstrated, by issuance of either a 510(k) or PMA clearance.

FDA cleared for treatment of Major Depressive Disorder - (Standard TMS)
MagPro® stimulators R20, R30, R30 with MagOption, X100, and X100 with MagOption are all FDA 510(k) cleared for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode (k170114, k150641 and k171481).

FDA cleared for treatment of Major Depressive Disorder – (Theta Burst)
MagPro® stimulators R30 with theta burst option, X100 and X100 with MagOption are all FDA 510(k) cleared for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode (k173620)

FDA cleared for adjunct treatment of Obsessive-Compulsive Disorder
MagPro stimulators R30, R30 with MagOption, X100 and X100 with MagOption are all FDA 510 (k) cleared as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD) (k193006)

FDA cleared for stimulation of peripheral nerves for diagnostic purposes
MagPro® stimulators R20, R30, R30 with MagOption, X100, and X100 with MagOption are all FDA 510(k) cleared for stimulation of peripheral nerves for diagnostic purposes (k160280, k061645, k091940)

The use of MagPro devices for other than FDA cleared intended uses is considered investigational. In accordance with US federal regulations, an IDE and/or IRB approval may be required for use of MagPro devices for uses distinct from the FDA cleared Indication(s) for Use. The sponsor is responsible for obtaining appropriate, required approvals. Please consult FDA's website (www.fda.gov) for more information.

For further information please contact:

MagVenture, Inc. 2300 Lakeview Parkway, Suite 700 Alpharetta GA 30009 Phone: +1 888-MAGPRO-4 (+1 888 624 7764) Fax: +1 678-809-1415 Email: Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!
www.magventure.com

Neuigkeiten und Veranstaltungen

Newsletter abonnieren (Englisch)

Erhalten Sie regelmäßig die neuesten Nachrichten über MagVenture und TMS.

disclaimer

Bitte beachten Sie

Sie verlassen nun den deutschen Bereich unserer Webseite und gelangen auf die englischsprachige Webseite von MagVenture. Für Unterstützung in deutscher Sprache empfehlen wir Ihnen, sich an unsere deutsche Niederlassung zu wenden.

Fortsetzen
gx leaving close


Subscribe to the MagVenture Newsletter

By clicking on the submit button, I confirm that I have read and agree to MagVenture’s Terms of Use.